Duke University stands as a leading institution for Ahc Medical Diagnosis and the comprehensive care of Alternating Hemiplegia of Childhood (AHC). Our dedicated team of specialists offers unparalleled expertise in managing this rare neurological condition, ensuring your child receives the most accurate diagnosis and effective treatment plan.
Multidisciplinary Team for Precise AHC Diagnosis
At Duke, your child benefits from a collaborative approach to ahc medical diagnosis. We assemble a team of experts from various disciplines, all specializing in pediatric AHC care. This includes specialists in neurology, cardiology, child behavioral health, medical genetics, neurodevelopment, neuropsychology, occupational therapy, physical therapy, psychiatry, sleep medicine, and speech therapy. This diverse expertise ensures all facets of your child’s condition are thoroughly evaluated, leading to a precise and holistic ahc medical diagnosis.
Extensive Experience in AHC and Related Rare Conditions
Duke’s experience extends beyond typical AHC cases. We are uniquely equipped to diagnose and manage atypical AHC presentations, including those not linked to the classic ATP1A3 gene mutation. Furthermore, our expertise encompasses related rare conditions caused by mutations in the ATP1A3 gene, such as febrile-induced paroxysmal weakness and encephalopathy (FIPWE), epileptic encephalopathy, relapsing encephalopathy with cerebellar ataxia (RECA), and CAPOS syndrome. This deep and broad experience is critical for accurate ahc medical diagnosis and tailored treatment strategies for complex cases.
Pioneering Research Advancing AHC Diagnosis and Treatment
Duke is at the forefront of AHC research, playing a pivotal role in understanding the genetic basis of this condition. Our researchers made the groundbreaking discovery of the ATP1A3 gene mutation as a leading cause of AHC in 2012. This discovery revolutionized ahc medical diagnosis and paved the way for ongoing research into new treatments and potential cures. Our commitment to research directly translates to improved diagnostic capabilities and access to cutting-edge therapies for our patients.
Access to Cutting-Edge Clinical Trials for AHC
As a Duke patient, your child may have the opportunity to participate in ongoing clinical trials focused on AHC. We are the lead center for the International AHC Research Consortium’s OBSERV-AHC study, a significant long-term initiative dedicated to understanding the natural progression of AHC and identifying factors influencing health outcomes. Our active involvement in research allows us to offer promising new therapies, such as gene replacement therapy, often before they become widely available. This access to clinical trials represents a significant advantage for families seeking the most advanced ahc medical diagnosis and treatment options.
Collaborative Care with Your Local Physician
We understand that families travel from across the nation and globally to access Duke’s specialized AHC care. To ensure seamless and comprehensive care, we prioritize collaboration with your child’s local doctor. By working closely with your existing healthcare provider, we ensure continuity of care and the most effective management plan, regardless of your location. This collaborative approach is vital for ongoing support following an ahc medical diagnosis.
Lifelong Care and Support for AHC Patients
Duke’s commitment to patients extends beyond childhood. We provide lifelong care for individuals affected by AHC, addressing the evolving needs of patients of all ages. Our comprehensive support services further assist families, including help with local lodging and transportation arrangements during evaluations, which can span several days. Through our partnership with Cure AHC, families can connect with a supportive community of other parents and children affected by AHC while receiving care at Duke. This holistic approach ensures that families receive not only expert ahc medical diagnosis and treatment but also long-term support and resources.
